"Myocarditis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Inflammatory processes of the muscular walls of the heart (MYOCARDIUM) which result in injury to the cardiac muscle cells (MYOCYTES, CARDIAC). Manifestations range from subclinical to sudden death (DEATH, SUDDEN). Myocarditis in association with cardiac dysfunction is classified as inflammatory CARDIOMYOPATHY usually caused by INFECTION, autoimmune diseases, or responses to toxic substances. Myocarditis is also a common cause of DILATED CARDIOMYOPATHY and other cardiomyopathies.
| Descriptor ID |
D009205
|
| MeSH Number(s) |
C14.280.238.625
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Myocarditis".
Below are MeSH descriptors whose meaning is more specific than "Myocarditis".
This graph shows the total number of publications written about "Myocarditis" by people in this website by year, and whether "Myocarditis" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 1 | 0 | 1 |
| 1998 | 1 | 0 | 1 |
| 2000 | 0 | 1 | 1 |
| 2001 | 2 | 1 | 3 |
| 2002 | 1 | 0 | 1 |
| 2003 | 2 | 1 | 3 |
| 2005 | 0 | 1 | 1 |
| 2006 | 1 | 0 | 1 |
| 2007 | 1 | 2 | 3 |
| 2008 | 0 | 2 | 2 |
| 2009 | 1 | 0 | 1 |
| 2010 | 3 | 0 | 3 |
| 2011 | 3 | 0 | 3 |
| 2012 | 2 | 0 | 2 |
| 2013 | 2 | 0 | 2 |
| 2014 | 2 | 1 | 3 |
| 2015 | 4 | 1 | 5 |
| 2016 | 0 | 1 | 1 |
| 2017 | 3 | 0 | 3 |
| 2018 | 1 | 0 | 1 |
| 2019 | 3 | 0 | 3 |
| 2020 | 7 | 1 | 8 |
| 2021 | 14 | 0 | 14 |
| 2022 | 7 | 0 | 7 |
| 2023 | 4 | 0 | 4 |
| 2024 | 4 | 1 | 5 |
| 2026 | 2 | 1 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Myocarditis" by people in Profiles.
-
Myocarditis and pericarditis: Case definition and guidelines for data collection, analysis, and presentation of immunization safety data. Vaccine. 2022 03 01; 40(10):1499-1511.
-
Fatal SARS-CoV-2 Inflammatory Syndrome and Myocarditis in an Adolescent: A Case Report. Pediatr Infect Dis J. 2021 02 01; 40(2):e72-e76.
-
Cardiovascular Toxicities Associated with Cancer Immunotherapies. Curr Cardiol Rep. 2017 03; 19(3):21.
-
Identification of gene signatures regulated by carvedilol in mouse heart. Physiol Genomics. 2015 Sep; 47(9):376-85.
-
Substance P receptor antagonism: a potential novel treatment option for viral-myocarditis. Biomed Res Int. 2015; 2015:645153.
-
Arrhythmias in children with ventricular assist devices. Cardiol Young. 2015 Feb; 25(2):255-60.
-
Analysis of clinical parameters and cardiac magnetic resonance imaging as predictors of outcome in pediatric myocarditis. Am J Cardiol. 2015 Feb 15; 115(4):499-504.
-
Infectious complications and outcomes in children supported with left ventricular assist devices. J Heart Lung Transplant. 2013 May; 32(5):518-24.
-
Conditional transgenic expression of TIR-domain-containing adaptor-inducing interferon-? (TRIF) in the adult mouse heart is protective in acute viral myocarditis. Basic Res Cardiol. 2011 Nov; 106(6):1159-71.
-
Effectiveness of mechanical circulatory support in children with acute fulminant and persistent myocarditis. J Card Fail. 2011 Jun; 17(6):487-94.